Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
26.41
+0.20 (0.76%)
Jun 4, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Arachidonic Acid | 302.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Arachidonic Acid Growth | 18.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Docosahexaenoic Acid | 79.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Docosahexaenoic Acid Growth | 23.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sialic Acid | 23.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sialic Acid Growth | -32.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 8.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | -73.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Beta-carotene | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Beta-carotene Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 271.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 17.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 164.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | -3.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|